Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sleep apnea
Biotech
Apnimed eyes FDA sleep apnea submission after positive results
AD109 met the trial's primary endpoint, reducing sleep apnea severity by a statistically significant 55.6% compared to baseline.
Darren Incorvaia
May 19, 2025 6:00am
FDA clears vibrating pad to nudge breathing in preterm newborns
Apr 8, 2025 11:00am
Resmed debuts wearable, at-home sleep apnea test
Apr 4, 2025 12:00pm
Apple pitches sleep apnea detection, OTC hearing aid features
Sep 10, 2024 1:30pm
FDA amplifies Inspire's sleep apnea nerve stimulator recall
Jul 9, 2024 12:00pm
FDA clears pulse ox-analyzing AI to spot sleep disorders
Feb 26, 2024 10:50am
